{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:40:35Z","timestamp":1776238835175,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chemotherapy and immunotherapy-induced peripheral neuropathy affects up to 68% of cancer patients and may persist long after treatment, substantially impairing daily functioning and quality of life. While exercise therapy has demonstrated benefits in lower-limb polyneuropathy (PNP), evidence for upper-extremity symptoms remains scarce. The VISCIPH B pilot study investigated the effect of two supervised exercise interventions for PNP of the upper extremities using exploratory analyses of symptom response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center randomized controlled pilot trial (DRKS00023287), 61 cancer patients with symptomatic upper-extremity PNP were randomized (1:1) to either (a) combined sensorimotor plus vibration exercise (PNPEX) or (b) moderate resistance exercise (MREX). Both interventions were carried out supervised twice weekly over 12\u00a0weeks. Feasibility outcomes included adherence, retention, assessment completeness, and safety of the exercise interventions. Symptom outcomes were assessed with the FACT\/GOG-Ntx questionnaire, measures of pain (NRS), depth sensitivity (Rydel-Seiffer tuning fork), and quality of life (EORTC QLQ-C30).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Feasibility criteria showed high adherence (86%) and retention (69%) rates. A total of 42 patients (mean age 53.3\u00a0years, 36% male) completed the intervention with no reported intervention-related adverse events. In the exploratory effect analyses, 50% of PNPEX participants (10\/20) were classified as responders, compared to 14% (3\/21) in MREX (OR\u2009=\u20095.45,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.043). FACT\/GOG-Ntx scores improved significantly in PNPEX (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017) but not in MREX (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.46), resulting in a significant difference between the two groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.05). Patient-reported outcomes revealed significant improvements in the PNPEX group regarding numbness and tingling (NRS), depth sensitivity at four of the eight tested bone sites and global health (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The VISCIPH B pilot trial confirmed the feasibility, safety, and acceptance of supervised exercise for upper-extremity PNP in cancer patients. Significant improvements in patient-reported and functional outcomes indicate that combined sensorimotor and vibration exercise can meaningfully reduce PNP symptoms and should be evaluated in larger trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-10459-7","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:49:13Z","timestamp":1773906553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Supportive care: Comparing exercise interventions for upper extremity polyneuropathy induced by chemo- or immunotherapy \u2014 VISCIPH B"],"prefix":"10.1007","volume":"34","author":[{"given":"Stefanie","family":"Siebert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarina","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Leuchte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freerk T.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Sonntag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"10459_CR1","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny M, Currie GL, Sena ES et al (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155:2461\u20132470","journal-title":"Pain"},{"key":"10459_CR2","first-page":"2261","volume":"22","author":"F Mols","year":"2014","unstructured":"Mols F, Beijers T, Vreugdenhil G et al (2014) Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer 22:2261\u20132269","journal-title":"Support Care Cancer"},{"key":"10459_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1177\/1534735418766615","volume":"17","author":"S Kneis","year":"2018","unstructured":"Kneis S, Wehrle A, Ilaender A et al (2018) Results from a pilot study of handheld vibration: exercise intervention reduces upper-limb dysfunction and fatigue in breast cancer patients undergoing radiotherapy: VibBRa study. Integr Cancer Ther 17:717\u2013727","journal-title":"Integr Cancer Ther"},{"key":"10459_CR4","first-page":"4981","volume":"30","author":"Y Ikio","year":"2022","unstructured":"Ikio Y, Sagari A, Nakashima A et al (2022) Efficacy of combined hand exercise intervention in patients with chemotherapy-induced peripheral neuropathy: a pilot randomized controlled trial. Support Care Cancer 30:4981\u20134992","journal-title":"Support Care Cancer"},{"key":"10459_CR5","volume":"33","author":"S Siebert","year":"2025","unstructured":"Siebert S, Kersten J, Tomanek A et al (2025) Lending a hand: supportive exercise therapy for cancer treatment-induced polyneuropathy of the upper extremity-VISCIPH A. Support Care Cancer 33:712","journal-title":"Support Care Cancer"},{"key":"10459_CR6","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","volume":"32","author":"DL Hershman","year":"2014","unstructured":"Hershman DL, Lacchetti C, Dworkin RH et al (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32:1941\u20131967","journal-title":"J Clin Oncol"},{"key":"10459_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00086","volume":"8","author":"N Kerckhove","year":"2017","unstructured":"Kerckhove N, Collin A, Cond\u00e9 S et al (2017) Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review. Front Pharmacol 8:86","journal-title":"Front Pharmacol"},{"key":"10459_CR8","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s40279-014-0207-5","volume":"44","author":"F Streckmann","year":"2014","unstructured":"Streckmann F, Zopf EM, Lehmann HC et al (2014) Exercise intervention studies in patients with peripheral neuropathy: a systematic review. Sports Med 44:1289\u20131304","journal-title":"Sports Med"},{"key":"10459_CR9","first-page":"2471","volume":"27","author":"F Streckmann","year":"2019","unstructured":"Streckmann F, Lehmann HC, Balke M et al (2019) Sensorimotor training and whole-body vibration training have the potential to reduce motor and sensory symptoms of chemotherapy-induced peripheral neuropathy-a randomized controlled pilot trial. Support Care Cancer 27:2471\u20132478","journal-title":"Support Care Cancer"},{"key":"10459_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13222973","author":"JA Tamayo Fajardo","year":"2025","unstructured":"Tamayo Fajardo JA, Le\u00f3n Parejo F (2025) Effectiveness of exercise and physiotherapy in chemotherapy-induced peripheral neuropathy: a systematic review. Healthcare. https:\/\/doi.org\/10.3390\/healthcare13222973","journal-title":"Healthcare"},{"key":"10459_CR11","first-page":"1019","volume":"26","author":"IR Kleckner","year":"2018","unstructured":"Kleckner IR, Kamen C, Gewandter JS et al (2018) Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer 26:1019\u20131028","journal-title":"Support Care Cancer"},{"key":"10459_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/NCC.0000000000000693","volume":"43","author":"S Dhawan","year":"2020","unstructured":"Dhawan S, Andrews R, Kumar L et al (2020) A randomized controlled trial to assess the effectiveness of muscle strengthening and balancing exercises on chemotherapy-induced peripheral neuropathic pain and quality of life among cancer patients. Cancer Nurs 43:269\u2013280","journal-title":"Cancer Nurs"},{"key":"10459_CR13","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/jamainternmed.2024.2354","volume":"184","author":"F Streckmann","year":"2024","unstructured":"Streckmann F, Elter T, Lehmann HC et al (2024) Preventive effect of neuromuscular training on chemotherapy-induced neuropathy: a randomized clinical trial. JAMA Intern Med 184:1046\u20131053","journal-title":"JAMA Intern Med"},{"key":"10459_CR14","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s40279-021-01596-6","volume":"52","author":"F Streckmann","year":"2022","unstructured":"Streckmann F, Balke M, Cavaletti G et al (2022) Exercise and neuropathy: systematic review with meta-analysis. Sports Med 52:1043\u20131065","journal-title":"Sports Med"},{"key":"10459_CR15","doi-asserted-by":"crossref","unstructured":"Cella DF, Tulsky DS, Gray G et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol [Internet] 11:570\u2013579. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/8445433\/","DOI":"10.1200\/JCO.1993.11.3.570"},{"key":"10459_CR16","doi-asserted-by":"crossref","unstructured":"Calhoun EA, Welshman EE, Chang C-H et al (2003) Psychometric evaluation of the Functional Assessment of Cancer Therapy\/Gynecologic Oncology Group-Neurotoxicity (Fact\/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. Int J Gynecol Cancer [Internet] 13:741\u2013748. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/14675309\/","DOI":"10.1136\/ijgc-00009577-200311000-00003"},{"key":"10459_CR17","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","volume":"41","author":"GR Norman","year":"2003","unstructured":"Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41:582\u2013592","journal-title":"Med Care"},{"key":"10459_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/BF02228367","volume":"37","author":"A Rydel","year":"1903","unstructured":"Rydel A, Seiffer W (1903) Untersuchungen \u00fcber das Vibrationsgef\u00fchl oder die sog. \u201cKnochensensibilit\u00e4t\u201d (Pall\u00e4sthesie). Arch Psychiatr Nervenkr 37:488\u2013536","journal-title":"Arch Psychiatr Nervenkr"},{"key":"10459_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI J Natl Cancer Inst 85:365\u2013376","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10459_CR20","doi-asserted-by":"crossref","unstructured":"Cheng HL, Lopez V, Lam SC et al (2020) Psychometric testing of the Functional Assessment of Cancer Therapy\/Gynecologic Oncology Group-Neurotoxicity (FACT\/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy. Health Qual Life Outcomes [Internet] 18:246. Available from: https:\/\/link.springer.com\/article\/10.1186\/s12955-020-01493-y","DOI":"10.1186\/s12955-020-01493-y"},{"key":"10459_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5960\/dzsm.2012.030","volume":"2012","author":"W Taube","year":"2012","unstructured":"Taube W (2012) Neurophysiological adaptations in response to balance training. Dtsch Z Sportmed 2012:273\u2013277","journal-title":"Dtsch Z Sportmed"},{"key":"10459_CR22","doi-asserted-by":"crossref","unstructured":"Zimmer P, Trebing S, Timmers-Trebing U et al (2018) Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: a randomized controlled trial. Support Care Cancer [Internet] 26:615\u2013624. Available from: https:\/\/idp.springer.com\/authorize\/casa?redirect_uri=https:\/\/link.springer.com\/article\/10.1007\/s00520-017-3875-5&casa_token=eua9nbevjzmaaaaa:pn2rwvt6cz8zyzol_hwrpften78nzro1rg9lkb_csir_cbs-fgccikk9uaep-ppjccvkun383pz7dg","DOI":"10.1007\/s00520-017-3875-5"},{"key":"10459_CR23","first-page":"351","volume":"28","author":"K Preti","year":"2024","unstructured":"Preti K, Davis ME (2024) Chemotherapy-induced peripheral neuropathy: assessment and treatment strategies for advanced practice providers. Clin J Oncol Nurs 28:351\u2013357","journal-title":"Clin J Oncol Nurs"},{"key":"10459_CR24","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.20.01399","volume":"38","author":"CL Loprinzi","year":"2020","unstructured":"Loprinzi CL, Lacchetti C, Bleeker J et al (2020) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol 38:3325\u20133348","journal-title":"J Clin Oncol"},{"key":"10459_CR25","doi-asserted-by":"crossref","unstructured":"Kleckner IR, Park SB, Streckmann F et al (2021) Clinical and practical recommendations in the use of exercise, physical therapy, and occupational therapy for chemotherapy-induced peripheral neuropathy. In:\u00a0Diagnosis, management and emerging strategies for chemotherapy-induced neuropathy: A MASCC Book. Springer International Publishing, Cham, pp 243\u2013252\u00a0","DOI":"10.1007\/978-3-030-78663-2_9"},{"key":"10459_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4158\/EP.13.1.5","volume":"13","author":"DS Oyer","year":"2007","unstructured":"Oyer DS, Saxon D, Shah A (2007) Quantitative assessment of diabetic peripheral neuropathy with use of the clanging tuning fork test. Endocr Pract 13:5\u201310","journal-title":"Endocr Pract"},{"key":"10459_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11071862","author":"SW Nielsen","year":"2022","unstructured":"Nielsen SW, Lindberg S, Ruhlmann CHB et al (2022) Addressing chemotherapy-induced peripheral neuropathy using multi-frequency vibrometry and patient-reported outcomes. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11071862","journal-title":"J Clin Med"},{"key":"10459_CR28","unstructured":"Krasnow SM, Rubin CT, Roeland EJ et al (2025) Low-intensity vibration to reduce symptoms and improve physical functioning in cancer survivors with chemotherapy-induced peripheral neuropathy: a pilot randomized trial. JCO Oncol Pract 2025:OP2400961"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10459-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10459-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10459-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:40:59Z","timestamp":1776235259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10459-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10459"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10459-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Cologne University\u2019s Faculty of Medicine (reference number 17-157) and has been registered in the German Clinical Trials Register on 10\/15\/2020 (DRKS-ID: DRKS00023287).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of ethics"}},{"value":"All participants provided written informed consent prior to inclusion in the study. During the study, personal data, treatment information, and disease-related data were collected. All collected data, including diagnostic findings, were handled in accordance with professional confidentiality obligations and data protection regulations, as defined by the General Data Protection Regulation (GDPR), the Declaration of Helsinki, and Good Clinical Practice (GCP) guidelines. Participation was voluntary, and refusal to participate had no impact on patient care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"345"}}